Altimmune Stock (NASDAQ:ALT), Quotes and News Summary

Q: What sector and industry does Altimmune (ALT) operate in?

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.

Open	$8.790
Close	$8.010
Volume / Avg.	4.042M / 4.326M
Day Range	7.860 - 8.805
52 Wk Range	2.090 - 14.840
Market Cap	$570.054M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	31.71%
Days to Cover	7.41

Recent News

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021.

Zacks

Jim Cramer Calls Nutanix 'The Perfect Enterprise Software Company For The Moment'

Cramer discusses Agnico Eagle Mines, Nutanix, Altimmune, CVR Energy and Quanta Services on CNBC's "Mad Money."

Avi Kapoor

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Altimmune (ALT) stock?

You can purchase shares of Altimmune (NASDAQ: ALT) through any online brokerage.

View our list of the best stock brokerages.

Who are Altimmune's (ALT) competitors?

Other companies in Altimmune’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Pharming (NASDAQ:PHAR) and AnaptysBio (NASDAQ:ANAB).

What is the target price for Altimmune (ALT) stock?

The latest price target for Altimmune (NASDAQ: ALT) was reported by HC Wainwright & Co. on Tuesday, May 14, 2024. The analyst firm set a price target for 12.00 expecting ALT to rise to within 12 months (a possible 49.25% upside). 12 analyst firms have reported ratings in the last year.

Current Stock Price for Altimmune (ALT)?

The stock price for Altimmune (NASDAQ: ALT) is $8.04 last updated May 17, 2024 at 7:31 PM EDT.

Does Altimmune (ALT) pay a dividend?

There are no upcoming dividends for Altimmune.

When is Altimmune (NASDAQ:ALT) reporting earnings?

Altimmune’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Altimmune (ALT) going to split?

There is no upcoming split for Altimmune.

What sector and industry does Altimmune (ALT) operate in?

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-